Floatz logo

VENLOR

Knee Pain Chronic

University of California, San FranciscoSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Knee Pain Chronic cohort.

Asset / SponsorPhaseRating
ROPIVACAINE
Poznan University of Medical Sciences
Phase 4BBB
DEXAMETHASONE
Poznan University of Medical Sciences
Phase 4BBB
Bxcl501
Poznan University of Medical Sciences
Phase 4BB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Brigham and Women's Hospital
Phase 4BB
Lopain
Sorrento Therapeutics, Inc.
Phase 3BB

View all 22 →

Same molecule, other indications

VENLOR is also rated in:

depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
major depressive disorderDormant
BB
Indicative ·
71 / 100
View asset →
VenlafaxineDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →